Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)
Forough Golsaz‐Shirazi(Tehran University of Medical Sciences), Fazel Shokri(Academic Center for Education, Culture and Research), Tohid Kazemi(Tehran University of Medical Sciences), Samira Farid(Academic Center for Education, Culture and Research), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Mahmood Jeddi‐Tehrani(Academic Center for Education, Culture and Research), Mohammad Mehdi Amiri(Tehran University of Medical Sciences), Jalal Khoshnoodi(University of Tehran), Felix Bohne(Helmholtz Munich), Ulrike Protzer(German Center for Infection Research), Lisa Wolff(Helmholtz Munich), Sebastian Maximilian Altstetter(Helmholtz Munich), Michael Chudy(Paul Ehrlich Institut), Motahareh Bahadori(Academic Center for Education, Culture and Research)
Cited by 13
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Viral hepatitis and liver cancer
|Philosophical Transactions of the Royal Society B Biological Sciences|2017|412
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312